Werbung
Werbung

PDSB

PDSB logo

PDS Biotechnology Corporation Common Stock

1.07
USD
Gesponsert
+0.07
+7.42%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

1.05

-0.02
-1.59%

PDSB Ergebnisberichte

Positives Überraschungsverhältnis

PDSB übertreffen die 25 der letzten 36Schätzungen.

69%

Nächster Bericht

Datum des nächsten Berichts
25. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-9.52%

PDS Biotechnology Corporation Common Stock earnings per share and revenue

On 13. Nov. 2025, PDSB reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 12.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, PDS Biotechnology Corporation Common Stock reported EPS of -$0.19, beating estimates by 12.68%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.33%, changed from $0.96 before the earnings release to $0.84 the day after.
The next earning report is scheduled for 25. März 2026.
Based on 4 analysts, PDS Biotechnology Corporation Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung